Citadel Advisors - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 81 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,692
-63.9%
10,700
-17.8%
0.00%
Q1 2023$10,215
-43.0%
13,013
-27.3%
0.00%
Q4 2022$17,911
+49.3%
17,911
+29.8%
0.00%
Q3 2022$12,000
-99.1%
13,800
-98.8%
0.00%
Q2 2022$1,323,000
+326.8%
1,191,453
+433.1%
0.00%
Q1 2022$310,000
-1.0%
223,498
+62.3%
0.00%
Q4 2021$313,000
-70.9%
137,684
-46.5%
0.00%
Q3 2021$1,074,000
-3.8%
257,551
+9.6%
0.00%
Q2 2021$1,116,000
-57.4%
234,919
-25.3%
0.00%
Q1 2021$2,617,000
+1448.5%
314,578
+814.5%
0.00%
Q4 2020$169,00034,4000.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,256,717$3,569,0000.16%
DOWLING & YAHNKE LLC 150,464$427,0000.04%
Aureus Asset Management, LLC 70,211$199,0000.02%
IEQ CAPITAL, LLC 72,217$205,0000.01%
Cohen Capital Management, Inc. 13,046$37,0000.01%
Creative Planning 487,737$1,385,0000.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 84,605$240,0000.00%
North Star Investment Management Corp. 4,000$11,0000.00%
MILLENNIUM MANAGEMENT LLC 62,559$178,0000.00%
MEEDER ASSET MANAGEMENT INC 2,132$6,0000.00%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders